A new Korean nomenclature for steatotic liver disease

키워드

참고문헌 (10)

1. Eslam M, "A new definition for metabolic dysfunction-associated fatty liver disease : An international expert consensus statement", J Hepatol, 73, pp.202~209 (2020)
2. Eslam M, "MAFLD : A consensus-driven proposed nomenclature for metabolic associated fatty liver disease", Gastroenterology, 158, pp.1999~2014 (2020)
3. Eslam M, "The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease", Hepatol Int, 14, pp.889~919 (2020)
4. Rinella ME, "A multisociety Delphi consensus statement on new fatty liver disease nomenclature", Hepatology, 78, pp.1966~1986 (2023)
5. Rinella ME, "A multisociety Delphi consensus statement on new fatty liver disease nomenclature", J Hepatol, 79, pp.1542~1556 (2023)
6. Kim GA, "Critical appraisal of metabolic dysfunction-associated steatotic liver disease : Implication of Janus-faced modernity", Clin Mol Hepatol, 29, pp.831~843 (2023)
7. Yoon EL, "Waiting for the changes after the adoption of steatotic liver disease", Clin Mol Hepatol, 29, pp.844~850 (2023)
8. Kang SH, "KASL clinical practice guidelines : Management of nonalcoholic fatty liver disease", Clin Mol Hepatol, 27, pp.363~401 (2021)
9. Gofton C, "MAFLD : How is it different from NAFLD?", Clin Mol Hepatol, 29(Suppl), pp.S17~S31 (2023)
10. Cho JY, "The growing burden of non-alcoholic fatty liver disease on mortality", Clin Mol Hepatol, 29, pp.374~376 (2023)